World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 11 July 2016
Main ID:  NCT01074476
Date of registration: 22/02/2010
Prospective Registration: Yes
Primary sponsor: University of British Columbia
Public title: Effects of Glucosamine on Joint Fluid in Osteoarthritis Patients
Scientific title: Investigation of Oral Glucosamine Effects on Synovial Fluid Viscosity and Viscoelasticity in Osteoarthritis Patients
Date of first enrolment: June 2015
Target sample size: 20
Recruitment status: Active, not recruiting
URL:  https://clinicaltrials.gov/show/NCT01074476
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Canada
Contacts
Name:     Christie Newton, Dr.
Address: 
Telephone:
Email:
Affiliation:  University of British Columbia
Name:     Dana Grecov, Dr.
Address: 
Telephone:
Email:
Affiliation:  University of British Columbia
Name:     Ezra Kwok, Dr
Address: 
Telephone:
Email:
Affiliation:  University of British Columbia
Key inclusion & exclusion criteria

Inclusion Criteria:

- are between 30 and 85 years of age

- are clinically diagnosed with moderate to severe knee OA

- are recommended for synovial fluid aspiration

Exclusion Criteria:

- are clinically diagnosed with inflammatory arthritis

- had previous joint surgery in the study knee

- had injection in the study knee within the past 12 months

- have taken glucosamine and/or chondroitin supplements within the past 3 months



Age minimum: 30 Years
Age maximum: 85 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Knee Osteoarthritis
Intervention(s)
Dietary Supplement: Glucosamine sulphate
Other: Placebo
Primary Outcome(s)
Changes in synovial fluid viscosity and viscoelasticity compared to baseline [Time Frame: 3 months]
Secondary Outcome(s)
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) total score [Time Frame: 3 months]
Secondary ID(s)
H10-00146
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history